Fig. 4From: Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNPComparison of the efficacy of dupilumab treatment according to disease severity. The improvement rate of FEV1, %FEV1, %FVC, ACT, treatment-step, and FeNO by asthma severity are shown. Mild-moderate; n = 50, Severe; n = 12. *p < 0.05, **p < 0.01 by unpaired t testBack to article page